Desk›Healthcare› Astonea Labs Ltd
Astonea Labs Ltd
BSE 544409 · NSE ASTONEALAB · ISIN INE0TG901011 · Group MT · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹275.50
+0.09%
BSE close, 28 August 2026
₹289.58 cr
1.1 cr shares · Micro cap
₹76.86 cr
as published
64.1× · —
EPS ₹4.30 · BV —
147.58 / 4.52
₹ cr, as filed
14
1 selected · 7%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -8.6% |
|---|---|
| Against 52-week low | +133.5% |
| Day change | +0.09% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹4.30 |
|---|---|
| Price / earnings | 64.07× |
| Price / book | — |
| Book value — derived, price ÷ P/B | — |
| Return on equity | — |
| Operating margin | — |
| Net margin | — |
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Mar-26 · Q | 81.29 | 3.10 | 3.08 | 10.34% | 3.81% |
| Sep-25 · Q | 66.29 | 1.42 | 1.03 | 8.25% | 2.14% |
| FY25-26 | 147.58 | 4.52 | 4.49 | 9.40% | 3.06% |
Quarter on quarter
- Revenue, quarter on quarter
- +22.6%
- Net profit, quarter on quarter
- +118.3%
- Operating margin, quarter on quarter
- +209 bps
Disclosure profile 14 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Results | 1 |
| Selected sub-total | 1 |
| Procedural | |
| General | 6 |
| AGM / EGM | 2 |
| Charter Amendment | 1 |
| Compliance Certificate | 1 |
| Outcome | 1 |
| SAST | 1 |
| Trading Window | 1 |
| Procedural sub-total | 13 |
| Total | 14 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group MT, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 98 trading days
14 filings · 1 selected · busiest 2026-08-21
Filing rhythm · the twelve most recent
2026-08-212026-10-09
SelectedProcedural
Filings
14 in the window · 8 earlier on record
-
9 October 2026 ·
Intimation Regarding Change In The Corporate Identification Number (CIN) Of The Company Consequent Upon Alteration Of The Object Clause Of The Memorandum Of Association
Please find enclosed herewith an Intimation regarding change in the Corporate Identification Number (CIN) of the Company consequent upon alteration of the Object Clause of the Memorandum ....
Company Update / General View filing →
-
8 October 2026 ·
Inc orporation Of Proposed Subsidiary- Longevity Science Private Limited
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 - Inc orporation of Proposed Subsidiary- Longevity Science Private Limited
Company Update / General View filing →
-
8 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed herewith the Certificate under Reg. 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, pertaining to the quarter ended 30.09.2026.
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
25 September 2026 ·
Closure of Trading Window
Intimation for Closure of Trading Window.
Insider Trading / SAST / Closure of Trading Window View filing →
-
22 September 2026 ·
Resubmission Of Financial Results For The Half Year Ended 31.03.2025 In Response To BSE Communication
Please find enclosed herewith re-submission of financial results for the half year and year ended 31.03.2025.
Result / Financial Results View filing →
-
18 September 2026 ·
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashish Gulati
Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →
-
17 September 2026 ·
Submission Of Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulation, 2015.
Please find enclosed herewith disclosure under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulation, 2015 as received from Mr. Ashish Gulati, Promoter of the Company.
Company Update / General View filing →
-
17 September 2026 ·
Disclosures Under Regulation 29(1) Of SEBI (Substantial Acquisition Of Shares & Takeovers) Regulations, 2011.
Please find enclosed herewith disclosure as per Regulation 29(1) of SEBI (Substantial Acquisition of shares & Takeovers) Regulation, 2011 as received from Mr. Ashish Gulati, Promoter of the Company.
Company Update / General View filing →
-
9 September 2026 ·
Appointment Of Internal Auditor
Intimation under Regulation 30-Appointment of Internal Auditor
Company Update / General View filing →
-
9 September 2026 ·
Board Meeting Outcome for Meeting Held On 9Th September, 2026.
Outcome of the Board Meeting held on 9th September, 2026.
Others / Outcome without intimation View filing →
-
21 August 2026 ·
Amendments to Memorandum & Articles of Association
Approval of Alteration in Object Clause of the Memorandum of Association ("MOA") of the Company
Company Update / Amendments to Memorandum & Articles of Association View filing →
-
21 August 2026 ·
Re-Appointment Of Ms. Pooja Singh As Director Of The Company
Re-appointment of Ms. Pooja Singh as Director of the Company
Company Update / General View filing →
-
21 August 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Scrutinizer's Reports and Voting Results of the 9th Annual General Meeting ("AGM") of the Company held on 21st August, 2026
AGM/EGM / AGM View filing →
-
21 August 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of 9th Annual General Meeting ("AGM") of the Company for the financial year 2025-26 held on 21st August, 2026
AGM/EGM / AGM View filing →
RSS feed for Astonea Labs Ltd · the 50 most recent filings